FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2588133053> ?p ?o ?g. }

• W2588133053 endingPage "256" @default.
• W2588133053 startingPage "249" @default.
• W2588133053 abstract "Background Amotosalen/ UVA ‐treated platelet concentrates ( PC s) have demonstrated efficacy for treating and preventing bleeding in clinical trials and in routine use; however, most studies were performed in haematology/oncology patients. We investigated efficacy during massive transfusion ( MT ) in general hospitalized patients. Methods Universal amotosalen/ UVA treatment ( INTERCEPT Blood System) of platelets was introduced at a large Austrian medical centre. We performed a retrospective cohort analysis comparing component use, in‐hospital mortality and length of stay after MT that included platelet transfusion, for two periods (21 months each) before and after implementation. Results A total of 306 patients had MT . Patients were mostly male (74%) and ≥18 years old (99%), including 93 liver transplant, 97 cardiac or vascular surgery and 51 trauma patients. There were no differences in demographics between the periods. Component use on the day and within 7 days of the MT event was unchanged post‐ IBS implementation, except trauma patients received fewer RBC s on the day. The mean ratio of RBC :platelets:plasma on the day of the MT was close to 1:1:1 in both periods, except for liver transplants with MT who received more plasma components. Overall, in‐hospital mortality (preimplementation = 27·6% vs. postimplementation = 24·0%; P = 0·51) and median time to discharge (preimplementation = 27 vs. postimplementation = 23 days; P = 0·37) did not change, except for cardiac and vascular surgery patients who were discharged earlier. Conclusion The introduction of amotosalen/ UVA ‐treated, pathogen‐reduced PC did not adversely affect clinical outcomes in massively transfused patients in terms of blood product usage, in‐hospital mortality and length of stay for a range of clinical indications for platelet transfusion support." @default.
• W2588133053 created "2017-02-24" @default.
• W2588133053 creator A5011765089 @default.
• W2588133053 creator A5016259501 @default.
• W2588133053 creator A5031778575 @default.
• W2588133053 creator A5034579113 @default.
• W2588133053 creator A5050631207 @default.
• W2588133053 creator A5051775780 @default.
• W2588133053 creator A5058789039 @default.
• W2588133053 creator A5073110497 @default.
• W2588133053 date "2017-02-15" @default.
• W2588133053 modified "2023-10-05" @default.
• W2588133053 title "Patient outcomes and amotosalen/<scp>UVA</scp>‐treated platelet utilization in massively transfused patients" @default.
• W2588133053 cites W1516128368 @default.
• W2588133053 cites W1638232714 @default.
• W2588133053 cites W1692288421 @default.
• W2588133053 cites W1941414043 @default.
• W2588133053 cites W1965673774 @default.
• W2588133053 cites W1967757030 @default.
• W2588133053 cites W1974622452 @default.
• W2588133053 cites W1974780655 @default.
• W2588133053 cites W1975459904 @default.
• W2588133053 cites W2042109117 @default.
• W2588133053 cites W2064908778 @default.
• W2588133053 cites W2084280207 @default.
• W2588133053 cites W2089329363 @default.
• W2588133053 cites W2105636185 @default.
• W2588133053 cites W2118384332 @default.
• W2588133053 cites W2120070528 @default.
• W2588133053 cites W2133226878 @default.
• W2588133053 cites W2133456254 @default.
• W2588133053 cites W2162642191 @default.
• W2588133053 cites W2299327636 @default.
• W2588133053 cites W2335174920 @default.
• W2588133053 cites W2413142209 @default.
• W2588133053 cites W2562127259 @default.
• W2588133053 doi "https://doi.org/10.1111/vox.12489" @default.
• W2588133053 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28198023" @default.
• W2588133053 hasPublicationYear "2017" @default.
• W2588133053 type Work @default.
• W2588133053 sameAs 2588133053 @default.
• W2588133053 citedByCount "29" @default.
• W2588133053 countsByYear W25881330532017 @default.
• W2588133053 countsByYear W25881330532018 @default.
• W2588133053 countsByYear W25881330532019 @default.
• W2588133053 countsByYear W25881330532020 @default.
• W2588133053 countsByYear W25881330532021 @default.
• W2588133053 countsByYear W25881330532022 @default.
• W2588133053 countsByYear W25881330532023 @default.
• W2588133053 crossrefType "journal-article" @default.
• W2588133053 hasAuthorship W2588133053A5011765089 @default.
• W2588133053 hasAuthorship W2588133053A5016259501 @default.
• W2588133053 hasAuthorship W2588133053A5031778575 @default.
• W2588133053 hasAuthorship W2588133053A5034579113 @default.
• W2588133053 hasAuthorship W2588133053A5050631207 @default.
• W2588133053 hasAuthorship W2588133053A5051775780 @default.
• W2588133053 hasAuthorship W2588133053A5058789039 @default.
• W2588133053 hasAuthorship W2588133053A5073110497 @default.
• W2588133053 hasBestOaLocation W25881330531 @default.
• W2588133053 hasConcept C126322002 @default.
• W2588133053 hasConcept C141071460 @default.
• W2588133053 hasConcept C144024400 @default.
• W2588133053 hasConcept C149923435 @default.
• W2588133053 hasConcept C167135981 @default.
• W2588133053 hasConcept C194409129 @default.
• W2588133053 hasConcept C2776689292 @default.
• W2588133053 hasConcept C2776738589 @default.
• W2588133053 hasConcept C2777396833 @default.
• W2588133053 hasConcept C2779867487 @default.
• W2588133053 hasConcept C2780084366 @default.
• W2588133053 hasConcept C71924100 @default.
• W2588133053 hasConcept C89560881 @default.
• W2588133053 hasConceptScore W2588133053C126322002 @default.
• W2588133053 hasConceptScore W2588133053C141071460 @default.
• W2588133053 hasConceptScore W2588133053C144024400 @default.
• W2588133053 hasConceptScore W2588133053C149923435 @default.
• W2588133053 hasConceptScore W2588133053C167135981 @default.
• W2588133053 hasConceptScore W2588133053C194409129 @default.
• W2588133053 hasConceptScore W2588133053C2776689292 @default.
• W2588133053 hasConceptScore W2588133053C2776738589 @default.
• W2588133053 hasConceptScore W2588133053C2777396833 @default.
• W2588133053 hasConceptScore W2588133053C2779867487 @default.
• W2588133053 hasConceptScore W2588133053C2780084366 @default.
• W2588133053 hasConceptScore W2588133053C71924100 @default.
• W2588133053 hasConceptScore W2588133053C89560881 @default.
• W2588133053 hasIssue "3" @default.
• W2588133053 hasLocation W25881330531 @default.
• W2588133053 hasLocation W25881330532 @default.
• W2588133053 hasOpenAccess W2588133053 @default.
• W2588133053 hasPrimaryLocation W25881330531 @default.
• W2588133053 hasRelatedWork W1930013658 @default.
• W2588133053 hasRelatedWork W1994006788 @default.
• W2588133053 hasRelatedWork W2032504685 @default.
• W2588133053 hasRelatedWork W2038519768 @default.
• W2588133053 hasRelatedWork W2065328143 @default.
• W2588133053 hasRelatedWork W2111669357 @default.
• W2588133053 hasRelatedWork W2116363559 @default.
• W2588133053 hasRelatedWork W2158389490 @default.

• next